Abstract
Schistosomiasis is a chronic helminthic infection that establishes a long-term, multi-year relationship with its human host in endemic populations. Acute schistosomiasis can occur in non-immune individuals 14–84 days post exposure to a primary infection or heavy reinfection, especially in high transmission areas. It has an average incubation period of 41.5 days. The symptoms of acute schistosomiasis was first described in Japan more than 100 years ago as Katayama fever. More recently, it is referred to as Katayama syndrome. The outbreak of acute schistosomiasis has a serious impact on an individual’s health and hinders the development of social economics in endemic areas. Effective prevention, early diagnosis, and treatment will significantly decrease the burdens associated with acute schistosomiasis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Li SZ, Luz A, Wang XH, et al. Schistosomiasis in China: acute infections during 2005-2008. Chin Med J (Engl). 2009;122:1009–14.
Lin CW, Li XR, Guo YH, et al. Simultaneous giant mucinous cystadenoma of the appendix and intestinal schistosomiasis: ‘case report and brief review’. World J Surg Oncol. 2014;12:385.
Li SZ, Zheng H, Abe EM, et al. Reduction patterns of acute schistosomiasis in the People’s Republic of China. PLoS Negl Trop Dis. 2014;8:e2849.
Zhang LJ, Gao FH, Xu ZM, et al. A cluster analysis of cases of schistosomiasis japonica using retrospective space-time permutation scan statistics. J Pathogen Biol. 2014;9:109–12.
Wang Q, Xu J, Zhang L, et al. Analysis of endemic changes of schistosomiasis in China from 2002 to 2010. Chin J Schisto Control. 2015;27:229–34. (in Chinese)
Zhao WX, Gao SF. Practical schistosomiasis. Bei**g: Renwei Publishing House; 1996. (in Chinese)
Hou XY, MaManus DP, Gray DJ, et al. A randomized, double-blind, placebo-controlled trial of safety and efficacy of combined praziquantel and artemether treatment for acute schistsomiasis japonica in China. Bull World Health Organ. 2008;86:788–95.
Zhan ZW, Chen F, Mao CX, et al. Survey on 732 acute schistosomiasis cases in Yanguan District in Wuchang. Chin J Schisto Control. 1991;3:60. (in Chinese)
Caldas IR, Campi-Azevedo AC, Oliveira LF, et al. Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection. Acta Trop. 2008;108:109–17.
Maizels RM, Pearce EJ, Artis D, et al. Regulation of pathogenesis and immunity in helminth infections. J Exp Med. 2009;206:2059–66.
Xu J, Peeling RW, Chen JX, et al. Evaluation of immunoassays for the diagnosis of Schistosoma japonicum infection using archived sera. PLoS Negl Trop Dis. 2011;5:e949.
Hosho K, Ikebuchi Y, Ueki M, et al. Schistosomiasis japonica identified by laparoscopic and colonoscopic examination. 2010;22:133–6.
Mahmoud AA. Praziquantel for the treatment of helminthic infections. Adv Int Med. 1987;32:193–206.
Zhou XN, Wang LY, Chen MG, et al. The public health significance and control of schistosomiasis in China—then and now. Acta Trop. 2005;96:97–105.
Li SM, Zhao ZY, Peng ZZ, et al. Evaluation on effect of treatment and assistance to advanced schistosomiasis patients in Hunan Province from 2004 to 2013. Zhongguo Xue ** Chong Bing Fang Zhi Za Zhi. 2014;26:362–6. (in Chinese)
Zhang LJ, Xu ZM, Qian YJ, et al. Endemic status of schistosomiasis in People’s Republic of China in 2015. Zhongguo Xue ** Chong Bing Fang Zhi Za Zhi. 2016;28:611–7. (in Chinese)
Ministry of Health, P.R. China. Manual of schistosomiasis prevention and control. 3rd ed. Shanghai: Shanghai Science and Technology Press; 2000. p. 63–4. (in Chinese)
Reboucas G. Clinical aspects of hepatosplenic schistosomiasis: a contrast with cirrhosis. Yale J Bio Med. 1975;48:369–76.
Warren KS, Reboucas G. Blood ammonia during bleeding from esophageal varices in patients with hepatosplenic schistosomiasis. N Eng J Med. 1964;271:921–6.
Bisseru B, Patel JS. Cruveilhier-Baumgarten (C-B) disease. Gut. 1989;30:36–137.
Ross AG, Sleigh AC, Li Y, et al. Schistosomiasis in the People’s Republic of China: prospects and challenges for the 21st Century. Clin Microbiol Rev. 2001;14:270–95.
McGarvey ST, Wu GL, Zhang S, et al. Child growth, nutritional status and schistosomiasis japonica in Jiangxi, People’s Republic of China. Am J Trop Med Hyg. 1993;48:547–53.
Nokes C, McGarvey ST, Shiue L, et al. Evidence for an improvement in cognitive function following treatment of Schistosoma japonicum infection in Chinese primary schoolchildren. Am J Trop Med Hyg. 1999;60:556–65.
Carvalho ACM, Horwith M. Hepatosplenic schistosomiasis mansoni associated with retarded growth and sexual development: endocrine evaluation. Gas Med Bahia. 1972;72:69–84.
Ross AGP, Li YS, Sleigh AS, et al. Epidemiologic features of Schistosoma japonicum among fishermen and other occupational groups in the Dongting Lake region (Hunan Province) of China. Am J Trop Med Hyg. 1997;57:302–8.
Bharti AR, Weidner N, Ramamooorthy S. Chronic schistosomiasis in a patient with rectal cancer. Am J Trop Med Hyg. 2009;80:1–2.
Ellis MK, Li Y, Hou X, et al. sTNFR-II and sICAM-1 are associated with acute disease and hepatic inflammation in schistosomiasis japonica. Int J Parasitol. 2008;38:717–23.
Hussain S, Hawass ND, Zaidi AJ. Ultrasonographic diagnosis of schistosomal periportal fibrosis. J Ultrasound Med. 1984;3:449–52.
Pereira LM, Domingues AL, Spinelli V, et al. Ultrasonography of the liver and spleen in Brazilian patients with hepatosplenic schistosomiasis and cirrhosis. Trans R Soc Trop Med Hyg. 1998;92:639–42.
Lambertucci JR, dos Santos Silva LC, Andrade LM, et al. Imaging techniques in the evaluation of morbidity in schistosomiasis mansoni. Acta Trop. 2008;108:209–17.
Kardorff R, Olveda RM, Acosta LP, et al. Hepatosplenic morbidity in schistosomiasis japonica: evaluation with Doppler sonography. Am J Trop Med Hyg. 1999;60:954–9.
Olveda DU, Olveda RM, Lam AK, et al. Utility of diagnostic imaging in the diagnosis and management of schistosomiasis. Clin Microbial. 2014;3:142.
Fataar S, Bassiony H, Satyanath S, et al. CT of hepatic schistosomiasis mansoni. Am J Roentgenol. 1985;145:63–6.
Preidler K, Riepl T, Szolar D, et al. Cerebral schistosomiasis: MR and CT appearance. Am J Neuroradiol. 1996;17:1598–600.
Passos MC, Silva LC, Ferrari TC, et al. Ultrasound and CT findings in hepatic and pancreatic parenchyma in acute schistosomiasis. Br J Radiol. 2009;82:e145–7.
Silva LCS, Maciel PE, Ribas JGR, et al. Treatment of schistosomal myeloradiculopathy with praziquantel and corticosteroids and evaluation by magnetic resonance imaging: a longitudinal study. Clin Infec Dis. 2004;39:1618–24.
Wu F, **e Z, Yuan S, et al. Studies on the diagnosis of schistosomiasis with IHA. Zhongguo Xue ** Chong Bing Fang Zhi Za Zhi. 1991;3:138–40. (in Chinese)
Hua W, Zhu Y, He W, et al. Analysis of fraction antigens of soluble egg antigen (SEA) of Schistosoma japonicum. Zhongguo Xue ** Chong Bing Fang Zhi Za Zhi. 1996;8:274–6. (in Chinese)
Zhu Y, Hua W, Liu Y, et al. A study on evaluation of efficacy of chemotherapy for schistosomiasis with fraction antigen of soluble egg antigen of Schistosoma japonicum. Zhongguo Xue ** Chong Bing Fang Zhi Za Zhi. 1996;8:321–4. (in Chinese)
Zhu Y, Socheat D, Bounlu K, et al. Application of dipstick bye immunoassay (DDIA) kit for the diagnosis of schistosomiasis mekongi. Acta Trop. 2005;96:137–41.
**a CM, Rong R, Lu ZX, et al. Schistosoma japonicum: a PCR assay for the early detection and evaluation of treatment in a rabbit model. Exp Parasitol. 2009;121:175–9.
Wichmann D, Panning M, Quack T, et al. Diagnosing schistosomiasis by detection of cell-free parasite DNA in human plasma. PLoS Negl Trop Dis. 2009;3:e422.
Li YS. Diagnosis and treatment of schistosomiasis. Bei**g: People’s Medical Publishing House; 2006. (in Chinese)
Ding SY. Village Doctor’s manual of schistosomiasis prevention and control. Changsha: Hunan People’s Publishing House; 2004. (in Chinese)
Ren GH. Schistosomiasis clinical medicine. Bei**g: People’s Medical Publishing House; 2009. p. 388–91. (in Chinese)
Parris V, Michie K, Andrews T, et al. Schistosomiasis japonicum diagnosed on liver biopsy in a patient with hepatitis B co-infection: a case report. J Med Case Rep. 2014;8:45.
Lyra LG, Recouças G, Andrade ZA. Hepatitis B surface antigen carrier state in hepatosplenic schistosomiasis. Gastroenterol. 1976;71:641–5.
Berhe N, Myrvang B, Gundersen SG. Reversibility of schistosomal periportal thickening/fibrosis after praziquantel therapy: a twenty-six month follow-up study in Ethiopia. Am J Trop Med Hyg. 2008;78:228–34.
Moreau R, Durand F, Poynard T, et al. Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology. 2002;122:923–30.
Lebrec D, Hillon P, Munoz C, et al. The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study. Hepatology. 1982;2:523–7.
Grace ND, Groszmann RJ, Garcia-Tsao G, et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology. 1998;28:868–80.
Cirera I, Feu F, Luca A, et al. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation. Hepatology. 1995;22:106–11.
Villanueva C, Ortiz J, Minana J, et al. Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding. Gastroenterology. 2001;121:110–7.
Escorsell A, Bandi JC, Andreu V, et al. Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension. Gastroenterology. 2001;120:161–9.
Ottesen LH, Flyvbjerg A, Jakobsen P, et al. The pharmacokinetics of octreotide in cirrhosis and in healthy man. J Hepatol. 1997;26:1018–25.
Luketic VA. Management of portal hypertension after variceal hemorrhage. Clin Liver Dis. 2001;5:677–707.
Westaby D, Macdougall BR, Williams R. Improved survival following injection sclerotherapy for esophageal varices: final analysis of a controlled trial. Hepatology. 1985;5:827–30.
Waked I, Korula J. Analysis of long-term endoscopic surveillance during follow-up after variceal sclerotherapy from a 13-year experience. Am J Med. 1997;102:192–9.
Seewald S, Sriram PV, Naga M, et al. Cyanoacrylate glue in gastric variceal bleeding. Endoscopy. 2002;34:926–32.
D’Amico G, Luca A, Morabito A, et al. Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis. Gastroenterology. 2005;129:1282–93.
Bureau C, Garcia-Pagan JC, Otal P, et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology. 2004;126:469–75.
Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology. 2005;41:386–400.
Seror J, Allouche C, Elhaik S. Use of Sengstaken-Blakemore tube in massive postpartum hemorrhage: aseries of 17 cases. Acta Obstet Gynecol Scand. 2005;84:660–4.
Condous GS, Arulkumarah S. The “tamponade test” in the management of massive postpartum hemorrhage. Obstet Gynecol. 2003;101:767–72.
Yang Z. Surgical strategy of diagnosis and treatment in advanced schistosomiasis. J Surg Concept Pract. 2010;15:301–4. (in Chinese)
Pal S. Current role of surgery in portal hypertention. Indian J Surg. 2012;74:55–66.
Zhang Y, Wen TF, Yan LN, et al. Preoperative predictors of portal vein thrombosis after splenectomy with periesophagogastric devascularization. World J Gastroenterol. 2012;18:1834–9.
Winslow ER, Brunt LM, Drebin JA, et al. Portal vein thrombosis after splenectomy. Portal vein thrombosis after splenectomy. Am J Surg. 2002;184:631–5.
Gines P, Cardenas A, Arroyo V, et al. Management of cirrhosis and ascites. N Engl J Med. 2004;350:1646–54.
Chen SX. Dwarf subtype of advanced schistosomiasis. In: Ren GH, editor. Schistosomiasis clinical medicine. Bei**g: People’s Medical Publishing House; 2009.
Liu JX, Li ZC, Cai DY. Colon proliferative subtype of advanced schistosomiasis. In: Ren GH, editor. Schistosomiasis clinical medicine. Bei**g: People’s Medical Publishing House; 2009.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Singapore Pte Ltd. and People's Medical Publishing House, PR of China
About this chapter
Cite this chapter
Xu, J., Qin, Zq., Zhao, Zy., Zhu, Yh., Zhou, J., Luo, Zh. (2022). Endemicity, Diagnosis and Treatment of Schistosomiasis in China. In: Zhou, XN. (eds) Tropical Diseases in China. Public Health in China, vol 5. Springer, Singapore. https://doi.org/10.1007/978-981-19-5707-9_2
Download citation
DOI: https://doi.org/10.1007/978-981-19-5707-9_2
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-5706-2
Online ISBN: 978-981-19-5707-9
eBook Packages: MedicineMedicine (R0)